why choose us

First received: March 14, 2023

Clinical Trial: A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 2 Diabetes Treated With Insulin

Study Type: INTERVENTIONAL


Official Title: A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults With Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)

Brief Summary: A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using basal-bolus insulin therapy.

Read more